Rationale: The burden of chronic obstructive pulmonary disease (COPD) is increasing, yet there are limited data on early life risk factors.
Chronic obstructive lung diseases including asthma and chronic obstructive pulmonary disease (COPD) are major public health issues worldwide (1) . COPD is among the leading causes of death, and asthma also imposes substantial morbidity and health care costs. Recently, asthma-COPD overlap syndrome (ACOS) has received much interest, but its definition has been evolving. As defined in the current joint guideline of Global Initiative for Asthma and the Global Initiative for Chronic Obstructive Lung Disease (GOLD) (1), ACOS is "characterized by persistent airflow limitation with several features usually associated with asthma and several features usually associated with COPD." Origins of ACOS are complex and still poorly understood. It is suggested that ACOS can be the result of progression from long-term or severe asthma to fixed airflow obstruction (2) (3) (4) (5) . ACOS may be simply the coexistence of asthma and COPD because both conditions are common. It is also hypothesized that ACOS is a single disease entity and may be differentiated from asthma and COPD by biomarkers, such as exhaled nitric oxide (6) . Compared with asthma or COPD alone, ACOS is more progressive in terms of frequency and severity of exacerbations, hospitalization, and poor quality of life (7) (8) (9) (10) .
Determining the causes for ACOS as opposed to asthma alone or COPD alone could help guide more targeted prevention and treatment. The role of early life determinants of asthma has been widely studied (11) ; however, there is increasing interest in early life origins of COPD. Fixed airflow obstruction is a common feature of COPD and ACOS, and it is therefore plausible that early life lung function may play a role in the etiology of both conditions.
Longitudinal studies have shown that poor lung function in early life tracks into early adulthood (12, 13) . Furthermore, it is now increasingly recognized that people entering adult life with incomplete lung growth are at increased risk of COPD, even in the absence of rapid decline during adult life (14) . A study by Lange and coworkers (15) of three independent cohorts compared lung function before the age of 40 years with subsequent lung function decline and COPD 22 years later. Half the people with COPD had a normal decline in FEV 1 but started from a lower baseline level of FEV 1 . Similarly, another study by Kalhan and coworkers (16) found that impaired lung function in subjects between 18 and 30 years of age predicted COPD 20 years later. The Melbourne Epidemiological Study of Childhood Asthma (17) reported that at the age of 50 years, subjects with COPD or current asthma showed evidence of lower lung function from childhood compared with subjects without asthma and those in remission from asthma, but ACOS was not examined. It is possible that lower lung function in early life is related to COPD and ACOS in adult life, but to date, no study has directly investigated this association.
We aimed to investigate associations between childhood lung function and current asthma, spirometrically defined COPD, and ACOS, and to estimate the prevalence of these conditions in early middle-age. Some of the results of this study have been previously reported in the form of an abstract (18) .
Methods

Study Design and Population
This analysis used data from TAHS (Tasmanian Longitudinal Health Study). The study methodology has been reported in detail elsewhere (19 
Lung Function Measurements
Lung function tests, including pre-BD and post-BD spirometry were conducted according to the joint American Thoracic Society and European Respiratory Society guidelines (20) . The predicted and % predicted values for spirometry were derived from the Global Lung Initiative reference equations (21) , which have been validated in an Australian population (22) .
Definitions
At age 45 years, current asthma was defined as having a positive response to the question "have you ever had asthma?" plus any asthma symptom or asthma medication use in the last 12 months. Participants who denied asthma history at 45 years, but had reported asthma in any of previous followups and were using asthma medication at 45 years were also considered as current asthma COPD at age 45 years was defined as post-BD FEV 1 /FVC less than the Global Lung Initiative lower limit of normal. Smoking was not included as a criterion in the COPD definition.
Participants were categorized into four mutually exclusive groups based on their asthma and COPD status: (1) neither asthma nor COPD (unaffected), (2) asthma alone, (3) COPD alone, and (4) ACOS. Thus, ACOS included all participants with both COPD and current asthma. Definitions of other variables are available in the online supplement.
At a Glance Commentary
Statistical Analysis
Characteristics of participants were compared across four groups defined at follow-up (45 yr) (unaffected, asthma alone, COPD alone, and ACOS) using chi-square tests for categorical variables and analysis of variance for continuous variables where appropriate.
Multinomial regression models were fitted to investigate associations between childhood lung function parameters at 7 years and asthma/COPD/ACOS at 45 years. Lung function parameters were converted to % predicted values. Because associations between childhood lung function and both ACOS and COPD alone were nonlinear, quartiles were used. The final multinomial model was adjusted for childhood lung infections, childhood asthma, maternal smoking, paternal smoking during childhood, and childhood socioeconomic status. Interactions were tested between childhood lung function and each of childhood asthma, maternal asthma, maternal smoking, paternal smoking during childhood, childhood lung infections, and adult active smoking, by including interaction terms into the model and using likelihood ratio tests.
Population prevalence and 95% confidence intervals (CI) for the entire Tasmanian population born in 1961 were extrapolated back from the observed prevalences by reweighting the known sampling fractions derived from the 1968, 1974, and 2002 surveys.
Lung function from 7 to 45 years was compared cross-sectionally among the four designated groups. Missing values for lung function at 13 and 18 years were multiply imputed (20 imputations).
All analyses were performed using Stata version 13.0 (Stata Corp., College Station, TX).
Results
Population Prevalence of COPD Alone, ACOS, and Asthma Alone
Of the 1,389 participants with post-BD lung function data available at 45 years, 1,355 had information about current asthma status. Of these, 959 participants had neither current asthma nor COPD (unaffected), 269 participants had current asthma alone, 59 participants had COPD alone, and 68 participants had ACOS. Once adjusted for the sampling weights, the prevalence of current asthma alone was 13.5% (95% CI, 11.8-15.4), COPD alone 4.1% (95% CI, 3.0-5.5), and ACOS 2.9% (95% CI, 2.2-3.7) (Figure 1 ). Therefore, among COPD population, ACOS accounted for 41% [2.9/(2.9 1 4.1)].
Demographic and Clinical Characteristics
There was no difference in age among the four designated groups. More of the asthma alone group were female than other groups. History of active smoking was significantly more frequent in ACOS (73.5%) and COPD alone (73%) than in unaffected (57%) groups. Childhood asthma, maternal asthma, and atopy were more prevalent in the ACOS and asthma alone groups. Median age (interquartile range) at asthma onset was 6 (2-24) and 4 (2-11) years for asthma alone and ACOS participants, respectively. Childhood lung infection was not significantly different across the four groups. ACOS and COPD participants had a higher prevalence of maternal smoking during childhood. Almost all ACOS (92.6%) and asthma alone (80.2%) participants had used inhaled medicines for breathing problems in the last 12 months, whereas it was not reported at all by COPD alone or unaffected participants. Within each clinical group, there was a fairly consistent reduction of post-BD lung function indices at 45 years compared with the unaffected group, with ACOS having the highest reduction, although not all between-group comparisons were significant (Table 1) .
Longitudinal Tracking of Lung Function among the Designated Groups
Pre-BD lung function from 7 years to 45 years among study participants is shown in Figure 2 . Participants with ACOS had the lowest pre-BD FEV 1 (% predicted values) over time. Participants with COPD alone or ACOS had significantly lower pre-BD FEV 1 /FVC (% predicted values) at all four time points compared with unaffected participants. Participants with COPD alone had significantly higher FVC at 7 and 13 years, whereas ACOS participants had significantly lower FVC at 45 years.
Associations between Childhood Lung Function and the Designated Groups
Associations were observed between FEV 1 /FVC ratio at 7 years and both COPD alone (odds ratio [OR], 5.76; 95% CI, 1.9-17.4) and ACOS (OR, 16.3; 95% CI, 4.7-55.9), whereas FEV 1 at 7 years was strongly associated with only ACOS (OR, 2.93; 95% CI, 1.32-6.52) but not with COPD alone (Table 2 ). In contrast, lung function at 7 years was not associated with current asthma alone. These findings did not change significantly after adjustment was made for active asthma or asthma severity at 7 years instead of presence/absence of asthma. Associations between childhood lung function and COPD alone, and ACOS remained significant after additional adjustment for sampling weights.
There was no evidence of effect modification by childhood lung infections, childhood asthma, maternal asthma, maternal smoking, or paternal smoking during childhood on the associations between childhood lung function and the disease groups (all P values for interaction . 0.1).
Because there was a large variation in childhood lung function values among the lowest quartiles of FEV 1 and FEV 1 /FVC, a sensitivity analysis was conducted after excluding those with less than 80% predicted (n = 76 and n = 13, respectively). In this analysis, the We further investigated the association between childhood FEV 1 /FVC and middleage COPD after stratifying by personal smoking status. We observed ORs of 7.8 (95% CI, 0.95-68; P = 0.06) in neversmokers and 5.0 (95% CI, 1.4-19; P = 0.02) in ever-smokers, but the difference in the estimates was not significant (P value for interaction = 0.9). We also observed a higher proportion of COPD never-smokers (64%) than of COPD ever-smokers (38%) to have lower childhood FEV 1 /FVC (see Table E1 in the online supplement).
However, we were unable to conduct a similar stratified analysis by smoking status for the association between childhood lung function and ACOS because of limited sample size in the never-smoking ACOS group.
Comparison of Spirometrically Defined COPD with GOLD Clinical Criteria
According to GOLD guidelines for the diagnosis, management, and prevention of COPD (23), key indicators for considering a diagnosis of COPD include dyspnea, chronic cough, chronic sputum production, family history of COPD, and a history of exposure to risk factors for the disease (i.e., tobacco smoke, smoke from home cooking and heating fuels, or occupational dusts and chemicals). An individual older than 40 years of age with any of key indicators should be diagnosed as COPD if spirometry confirms the presence of persistent airflow limitation. In our study, 95% of COPD participants (97% of COPD alone and 93% of ACOS) had at least one key indicator, thus fulfilling the GOLD clinical diagnosis of COPD.
Discussion Principal Findings
This study shows that lower lung function at age 7 years is associated with an increased risk of COPD and ACOS by middle age. To our knowledge, this is the first report of lower childhood lung function as a risk factor for adult COPD and ACOS, providing further evidence on the early life origins of these diseases.
Definition of Outcomes
In clinical practice, symptoms and history of exposure to risk factors are taken into account in COPD diagnosis. However, in this study, the definition of COPD was solely based on spirometry to have a sensitive definition. Because the population was relatively young, symptoms were not included to avoid missing asymptomatic participants. Smoking was not part of the definition to include both 
Prevalence of Outcomes
We estimated the reweighted prevalence of ACOS and COPD alone to be 2.9% and 4.1%, respectively, at 45 years of age. Few studies have attempted to quantify the prevalence of ACOS and it would be expected to vary depending on age and definition. Studies have investigated ACOS among patients with COPD and have reported its prevalence to be between 15 and 55% (24) (25) (26) (27) . Our estimate of 41% is within this range. Whether ACOS can be seen as an independent disease entity, a form of severe asthma, or simply coexistence of the two common conditions remains a question for debate (7, 8) . In our study, the reweighted prevalence of ACOS is higher than the probability of having both asthma and COPD, suggesting that ACOS is not just the coexistence of asthma and COPD by chance alone.
Associations between Childhood Lung Function and COPD and ACOS
Our study is the first to examine the link between early life lung function and ACOS. We found that ACOS participants showed evidence of persistently lower FEV 1 and FEV 1 /FVC from childhood. This suggests that poorer childhood lung function tracked to early adult life, leading to impaired maximally attained lung function. This in turn leads to poorer lung function in middle age, even when lung function decline is not accelerated. Our finding on the associations between lung function at age 7 years and COPD bridges the gap between earlier findings of Stern and coworkers (12) and others (15, 16 coworkers (12) reported that poor lung function shortly after birth tracked to age 22 years. Kalhan and coworkers (16) reported a link between poor lung function in early adulthood and subsequent COPD. Lange and coworkers (15) found half of COPD cases could be attributed to low lung function in adulthood even without steeper lung function decline. Adding to the wellrecognized pathway to COPD from steep lung function decline, we now provide evidence of another long-term pathway to COPD from poor lung function in childhood. Moreover, our data show that those who developed COPD by middle age had persistently lower FEV 1 /FVC over time from childhood (Figure 2) , which is consistent with the observation by Tai and coworkers (17) . This study highlights that low childhood lung function is a risk factor for COPD (and ACOS) independent of smoking. It has been reported that the effect of cigarette smoking on lung function decline with age is most evident in young adults with preexisting airflow obstruction (16) . Furthermore, it has also been shown that reduced lung function in infancy is associated with wheeze at 18 years, only in smokers (28) . We observed the effect of lower childhood lung function on subsequent COPD to be greater in never-smokers than ever-smokers but a test for interaction between childhood lung function and smoking was not statistically significant. However, the small sample size might have limited the statistical power. It is also possible that the intensity of smoking in smokers may have differed between our study and others.
A complex relationship exists among asthma, lung function, COPD, and ACOS. On one hand, childhood asthma has been associated with impaired childhood lung function (29) , adult asthma, and COPD (30) . Moreover, poor lung function has been described as a marker of asthma severity and more severe asthma was strongly associated with COPD (17) . However, childhood asthma or its severity did not confound our results. On the other hand, both childhood asthma (31, 32) and poor childhood lung function (13) may result from impaired lung function at birth. Therefore, a synergistic effect between poor childhood lung function and "early life asthma background" or "asthma predisposing factors" may also contribute to COPD and ACOS development. However, we did not observe any such effect modification by childhood asthma or maternal asthma. However, because of the small sample sizes for the COPD alone and ACOS groups, we cannot rule out the possibility of such interaction.
In our study, participants with asthma or ACOS had the highest prevalence of atopy as would be expected. However, the prevalence of atopy was also high in COPD and unaffected participants. This is partly because our sample was enriched for asthma and cough. However, our reweighted population prevalence of atopy was also high, which is consistent with Australia being among countries with the highest prevalence of atopy (33) . We did not observe atopy to be an effect modifier for associations between childhood lung function and COPD or ACOS.
The age of the participants in our study was younger than in most clinical trials in COPD. Our participants, therefore, may represent an early form/stage of COPD of relatively low prevalence. Consistently, mild COPD was predominant in our study, with 70% of the COPD alone group having FEV 1 greater than or equal to 80% of predicted values, which is substantially higher than reported elsewhere (34, 35) . Moreover, we observed that participants with COPD alone did not report any medication use for breathing problems in the prior year. Reporting no medication use could just reflect underdiagnosis and undertreatment, which is common in early COPD (35) (36) (37) .
Strengths and Limitations
Our study has strengths and limitations. The main strength is that TAHS is one of the world's longest-running cohort studies in which data on lung function and respiratory health have been collected prospectively from childhood. Using information about asthma status at multiple follow-ups helps minimize misclassification of asthma because of recall bias (38) . The use of post-BD spirometry to define COPD at age 45 years is also a strength of this study compared with the use of pre-BD spirometry by other studies (2), which also looked at COPD and ACOS. The relatively small sample sizes for the ACOS and COPD alone groups are a limitation. In addition, like most other studies initiated in that era, we did not have post-BD spirometry at 7 years. However, any potential that our data were confounded by the BD response that might have been seen in more active asthma was taken into account by analyses allowing for the presence of childhood asthma and asthma severity. There was a large variation in lung function values in the lowest quartiles of FEV 1 and FEV 1 /FVC, but the sensitivity analysis confirmed that our observed associations were not driven by those with extremely low lung function.
Conclusions
Our study is the first to show that lower lung function in early life may have long-term consequences for the development of COPD and ACOS by middle age. Our study suggests that screening of lung function in school-age children may provide an opportunity to detect children likely to have ongoing poorer lung health, such as those with lung function below the lower limit of normal. Multifaceted intervention strategies could then be implemented to reduce the burden of COPD and ACOS in adulthood. Further research is needed to better understand the risk factors for lower lung function in children and also further understanding of risk factors over adulthood that interact with lower lung function to increase the risk of rapid lung function decline. n Author disclosures are available with the text of this article at www.atsjournals.org.
